Mesoblast Limited (MEOBF) Stock Statistics & Valuation Metrics

Mesoblast Limited has a market cap or net worth of $1.43B. The enterprise value is ―.

Mesoblast Limited has 1,277,782,200 shares outstanding. The number of shares has decreased by -2.65% in one year.

Mesoblast Limited’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Mesoblast Limited is -7.48. Mesoblast Limited’s PEG ratio is -5.18.

In the last 12 months, Mesoblast Limited had revenue of 5.90M and earned -87.96M in profits. Earnings per share was -0.09.

In the last 12 months, operating cash flow was -27.53M and capital expenditures -331.00K, giving a free cash flow of -27.86M billion.

Mesoblast Limited pays an annual dividend of ―, resulting in a dividend yield of ―

Mesoblast Limited upcoming earnings date is May 28, 2025, TBA Not Confirmed.

Mesoblast Limited as a current ratio of 1.18, with Debt / Equity ratio of 24.76%

In the past 12 months, Mesoblast Limited has paid 191.00K in taxes.

Mesoblast Limited EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Mesoblast Limited has $62.56M in cash and marketable securities with $118.92M in debt, giving a net cash position of $56.36M billion.

Gross margin is -595.87%, with operating margin of -1425.74%, and net profit margin of -1490.27%.

The average price target for Mesoblast Limited is $1.87, which is 11.43% higher than the current price. The consensus rating is Moderate Buy